Posts Under Featured Articles Category
[FEATURED ARTICLE] Cryonics, July-August 2012 By Chana de Wolf There are few people in the world who blaze a trail through life like Todd Huffman does. Whether he is assisting in a cryonics case, developing new microscope technologies, or helping to stabilize technology infrastructure in conflicted environments, there is nothing run-of-the-mill about anything he is involved with. And since he… Read more »
[FEATURED ARTICLE] Cryonics, July-August 2012 By James D. Miller, Ph.D. I came to Alcor through contemplating the Singularity. Previously, I had heard of cryonics but didn’t have enough trust in human innovation to believe that a frozen body could ever be revived. What I didn’t take into account was the likelihood that artificial intelligence (AI) would soon supercharge scientific progress…. Read more »
[FEATURED ARTICLE] Cryonics, May-June 2012 by Ralph C. Merkle, Ph.D. [The opinions expressed herein are those of the author and do not necessarily reflect those of Alcor or its Board.] Abstract Cryopreserved patients must be cared for for at least decades and some anticipate centuries. During this time, some caretaker organization must look after the patients. This involves paying the… Read more »
[FEATURED ARTICLE] Cryonics, May-June 2012 The End of Illnessby David B. Agus, MD. Free Press, 2011. Reviewed by Steve Bridge So, here’s one of those choice games that young people play – We have a new medication. 75% of those who take it will become ageless and immortal; 25% die immediately. The only way to know which is which is… Read more »
[FEATURED ARTICLE] Cryonics, March-April 2012 By Mike Perry Alzheimer’s disease (AD) is the most common form of dementia. There is no cure, it worsens as it progresses, and it is uniformly fatal, though typically requiring 7-14 years to run its course from what up to now have been the first detectable, identifiable symptoms. (Symptoms may show up earlier than this… Read more »
[FEATURED ARTICLE] Cryonics March-April 2012 By Rudi Hoffman Background on Cryonics Funding By now, most members and potential members reading these words are aware that Alcor is anticipating enacting an historic — and no doubt much discussed — new pricing model. This will almost certainly impact nearly everyone reading this article, even members of other cryonics organizations or those intending… Read more »
[FEATURED ARTICLE] Cryonics, January-February 2012 By Chana de Wolf Following an arduous search lasting many months, Alcor was pleased to hire long-time member Max More to the CEO position in January 2011. Max comes to Alcor with an extensive background as a writer, speaker, and philosopher of futurist topics and as an activist for life extension technologies, including cryonics. Readers… Read more »
[FEATURED ARTICLE] Cryonics, January-February 2012 By R. Michael Perry [Update of an article that appeared in Cryonics, 1st Q. 2010] INTRODUCTION As cryonicists we want to be cryopreserved with mental faculties intact. Prospects for this are threatened if one has a brain disorder such as malignancy or Alzheimer’s disease—or simply advancing old age, with its usual risk of strokes and… Read more »
[FEATURED ARTICLE] By Aschwin de Wolf Cryonics, January-February 2012 Introduction Many people who have made cryonics arrangements tend to think of it as a “back-up plan” in case hoped-for breakthroughs in rejuvenation will be too late to help them or as protection against lethal accidents. Their confident hope is that, if other workarounds don’t pan out, they will die from… Read more »
[FEATURED ARTICLE] Cryonics, 4th Quarter 2011 By Chana de Wolf It may come as no surprise that many cryonicists are avid science fiction fans. After all, cryonics is only necessary because we can’t already reverse aging and cure lethal diseases, so being on board to see the (possibly far-distant) future is requisite. Indeed, cryonics is somewhat of a science fiction… Read more »
